Picture EBD Group BIO-Europe Spring 2025 Milan to 14 Mar 650x100px

Organisation › Details

DB Speciality Invest GmbH & Co. KG

	Start	2023-02-27 existent
	Group	BRUCHMANN Group (family of Dietrich Bruchmann)
	Industry	investment management
	Industry 2	MedTech (medical technology)
	Person	Bruchmann, Dietrich (Nuvisan 2022 Managing Director of Nuvisan Pharma Holding GmbH)

	Region	Neu-Ulm
	Country	Germany
	City	n. a.
		Address record changed: 2023-03-17

Basic data	Employees	n. a.


		Record changed: 2024-12-29

Picture Berlin Partner Events Bionnale 2025 May HealthCapital 650x200px

More documents for BRUCHMANN Group (family of Dietrich Bruchmann)

[1] TolerogenixX GmbH. (7/6/23). "Press Release: TolerogenixX Expands Phase II Immune-tolerance Trial and Closes EUR 12 million Series A Financing"....
[2] VisionHealth GmbH. (2/27/23). "Press Release: VisionHealth Raises 3 Million Euro to Finance Extended COPD and Asthma Study for Market Preparation of Kata, an Innovative Digital Therapeutic for Improved Inhalation". Munich....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]